Webinar - 18 December 2024 Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases
Article - 13 September 2023 Labcorp expanding bioanalytical service offering in the Asia-Pacific region with an integrated laboratory in Singapore
Press Release - 16 May 2023 Labcorp and BML announce expansion of clinical laboratory testing capabilities in Japan
Info Sheet - 12 November 2024 Labcorp Global Trial Connect Site workflow facilitation Read Moreabout Labcorp Global Trial Connect Site workflow facilitation
Poster - 20 October 2024 Receptor occupancy assay development challenges for rare targets of bispecific drugs Read Moreabout Receptor occupancy assay development challenges for rare targets of bispecific drugs
Poster - 28 July 2024 Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials Read Moreabout Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials
Poster - 19 May 2024 Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists Read Moreabout Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists
Poster - 5 May 2024 Development and validation of a fit-for-purpose biomarker LC-MS/MS assay measuring 15 plasma bile acids Read Moreabout Development and validation of a fit-for-purpose biomarker LC-MS/MS assay measuring 15 plasma bile acids
Poster - 4 May 2024 Validation of a flow cytometry-based basophil degranulation assay for use in multi-centric clinical trials Read Moreabout Validation of a flow cytometry-based basophil degranulation assay for use in multi-centric clinical trials
Webinar - 18 December 2024 Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases Read Moreabout Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases
Video - 25 April 2024 From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME) Read Moreabout From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)
Video - 8 April 2024 Challenges and opportunities for bioanalytical support of new drug modalities Read Moreabout Challenges and opportunities for bioanalytical support of new drug modalities
Aaron Ledvina, PhD Senior Scientific Support Specialist, LC-MS Bioanalytical Services Read Moreabout Aaron Ledvina, PhD
Amanda Wilson Global Director of Method Development & Validation, LC-MS Bioanalytical Services Labcorp Read Moreabout Amanda Wilson
Colin Guy, PhD Senior Manager Assay Development, Method Development & Validation Read Moreabout Colin Guy, PhD
Daniel Sikkema, PhD Executive Director, Global Immunochemistry Bioanalytical Services Read Moreabout Daniel Sikkema, PhD
Eric Thomas, PhD Global Director of Method Development & Validation, LC-MS Bioanalytical Services Read Moreabout Eric Thomas, PhD
Graeme Evans Global Director, Method Development & Validation Immunochemistry Read Moreabout Graeme Evans
Henry Fisher, PhD Assay Development Scientist, Method Development & Validation Read Moreabout Henry Fisher, PhD
James Tunaley, PhD Study Director & Scientist, Molecular Bioanalysis Read Moreabout James Tunaley, PhD
Jill Uhlenkamp, PhD Senior Method Development Manager, Immunochemistry Read Moreabout Jill Uhlenkamp, PhD
Lee Goodwin, PhD Executive Director, Global LC-MS Bioanalytical Services Read Moreabout Lee Goodwin, PhD
Leonard Bell, PhD Lead Assay Development Scientist, Method Development & Validation Read Moreabout Leonard Bell, PhD
Rachel Smith, PhD Assay Development Scientist, Method Development & Validation Read Moreabout Rachel Smith, PhD
Stephanie Cape, PhD Head of Research and Development and Delivery, Scientific Affairs Read Moreabout Stephanie Cape, PhD